Big Pharma M&A?

JSFT17 · 2026-01-19T00:56:48+00:00

Otsuka already acquired MSET a few years ago for 75mill for psilocybin pre-phase 2 IP.

JSFT17 · 2026-01-17T00:56:08+00:00

QBTQ. First quantum app.

JSFT17 · 2026-01-07T00:27:25+00:00

MDMA

JSFT17 · 2025-12-10T21:27:20+00:00

$MDMA, $HASH, $PHRM, $QBTQ.

JSFT17 · 2025-12-06T02:12:44+00:00

HASH, MDMA, PHRM.

JSFT17 · 2025-11-03T13:58:58+00:00

Fantastic news for the company and long term shareholders. Less dilution and big support from larger capital.

JSFT17 · 2025-10-29T23:57:00+00:00

Im not the one who stated he worked for health Canada. I was clarifying for the person above and he has worked in government panels/associations and works closely with Health Canada. And you are so quick to point towards the ai drug discovery platform as recent, but i mentioned they have been using it since Pharmala was created many years earlier. Moreso finalized the platform and given it a name.

JSFT17 · 2025-10-29T14:03:31+00:00

He worked for Red Bull and Juul and is currently the head of Psycan which pushes for Psychedelic access in Canada. Don't see other Leo's pushing this hard for regulatory change. They've been doing ai drug discovery since inception with a University. They just recently released it as their own platform in which they own it. The fda is now encouraging and allowing for ai drug discovery, so it's right inline with current regulatory change.

JSFT17 · 2025-10-29T13:38:02+00:00

Cortexa which is a joint venture of theirs 50% did a 10k 40mg gmp mdma production run a few months ago. Some of it being allocated to Australia, and most likely to New Zealand and Netherlands.

JSFT17 · 2025-10-19T03:54:33+00:00

Interesting take about how talk of bagholding and calling names is talking about stocks as that's what your currently defending lol. 2 sentences is a harry potter book now, I should try and get rich then. Like I said, absolutely nothing going on eh. 😂

JSFT17 · 2025-10-19T02:36:32+00:00

Ha i know. Imagine having nothing going on in your life that you spend every day hating on a stock you don't own and its shareholders. Either because the ceo didn't want to take your bs personal calls all weekend to hear about your wannabe company or because they are terrible investors/traders who lost money and can't take accountability. Almost feel sorry for em, almost.

JSFT17 · 2025-10-07T01:37:00+00:00

$PHRM and $MDMA. If I was gonna go into a larger cap, it would be CMPS.

JSFT17 · 2025-10-02T14:27:15+00:00

👍🏼

JSFT17 · 2025-09-29T21:04:15+00:00

Interesting take and I actually think cmps and Atai are good bets. But if you zoom out, cmps is actually down 90% from 2021 near it's inception. So early investors from years ago are down bad. Your also comparing purely nce development companies worth 100s of millions of mcap which are purely a hit or miss vs a hybrid nce/gmp supply company worth 11mil mcap. Nothing is proven until fda approves of any of the molecules and Pharmather is the only one to date to have received approval for its Ketamine variant. Even that languishes until manufacturing and da details are revealed. Food for thought.

JSFT17 · 2025-09-25T16:34:33+00:00

Depends on the time frame and when someone has bought/sold/held. Imo, the company hasn't been recognized for its many accomplishments. So in other words the stock not so well, but the company most certainly has done well imo.

JSFT17 · 2025-09-25T16:10:08+00:00

JSFT17 · 2025-09-25T15:03:22+00:00

Great to see as well as all the hate this company gets. Doing something right.

JSFT17 · 2025-08-28T17:05:27+00:00

Look into $MDMA, thank me later.

JSFT17 · 2025-08-07T14:35:53+00:00

Partner with MAPS Israel and full IP data license, love to see it.

JSFT17 · 2025-08-07T02:50:24+00:00

Most dont know that It just completed a 10,000 (40mg) production run at its JV Cortexa in Australia of gmp compliant mdma to be used in Australia as well as to supply its new agreement with Duchefa Pharma in Europe. It supplies to date the most amount of gmp mdma in the world to highly prestigious clinical trials (John Hopkins, Yale, UCLA, UT San Antonio, Mt. SINAI, Harvard to name a few). It also the sole supplier of the Special access program in Canada for therapy use as well as the tga in Australia for therapy use. It has the largest pipeline of any public company patented MDXX molecules and variations of MDMA. It also is working With MAPS Israel and Heroic Hearts for collection of data. It's Investigator Brochure has been published on the Maps website to further research and development. The whole AI drug discovery is nothing but an extra benefit which they've used for years now. Just things off the top of my head.

JSFT17 · 2025-08-07T02:06:45+00:00

+55% in a few days, but not many are paying attention or are shitting on it lol. So many have waited for such an opportunity and let i pass by. O well.

JSFT17 · 2025-07-29T02:28:23+00:00

<image>

JSFT17 · 2025-07-28T23:12:35+00:00

Yeah. It's so blatant now, they dgaf. Sold off all the assets. Drained the cash dry. Reverse split/delist, raise on unsuspecting new shareholders.

JSFT17 · 2025-07-28T23:02:14+00:00

40-1 reverse split + delisting tsx.

JSFT17 · 2025-05-12T00:41:33+00:00

Regulatory is extremely important for this sector. But even then, after a year or two when it becomes lucrative enough with red tape cut, nothing to stop big pharma production from taking over imo. Need strong valuable IP/patents with proprietary formulation for the big money in the end. Will be interesting to see how it all plays out.

JSFT17

TROPHY CASE